Cargando…
Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839724/ https://www.ncbi.nlm.nih.gov/pubmed/31270163 http://dx.doi.org/10.1136/gutjnl-2019-318999 |
| _version_ | 1783467483104018432 |
|---|---|
| author | Musso, Orlando Beraza, Naiara |
| author_facet | Musso, Orlando Beraza, Naiara |
| author_sort | Musso, Orlando |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6839724 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-68397242019-11-12 Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor Musso, Orlando Beraza, Naiara Gut Commentary BMJ Publishing Group 2019-10 2019-07-03 /pmc/articles/PMC6839724/ /pubmed/31270163 http://dx.doi.org/10.1136/gutjnl-2019-318999 Text en © Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Commentary Musso, Orlando Beraza, Naiara Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title | Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title_full | Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title_fullStr | Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title_full_unstemmed | Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title_short | Hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| title_sort | hepatocellular carcinomas: evolution to sorafenib resistance through hepatic leukaemia factor |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839724/ https://www.ncbi.nlm.nih.gov/pubmed/31270163 http://dx.doi.org/10.1136/gutjnl-2019-318999 |
| work_keys_str_mv | AT mussoorlando hepatocellularcarcinomasevolutiontosorafenibresistancethroughhepaticleukaemiafactor AT berazanaiara hepatocellularcarcinomasevolutiontosorafenibresistancethroughhepaticleukaemiafactor |